MedComm – Biomaterials and Applications,
Journal Year:
2023,
Volume and Issue:
2(3)
Published: Sept. 1, 2023
Abstract
Nanobodies
(Nbs)
are
the
variable
domain
of
heavy‐chain
antibodies
derived
from
blood
camelids
or
sharks.
smallest
antibody
fragment
with
intact
antigen‐binding
ability.
Compared
to
conventional
antibodies,
nanobodies
have
unique
properties
such
as
small
size,
excellent
stability
and
solubility,
low
immunogenicity,
ability
recognize
hidden
epitopes,
high
tissue
penetration,
industrialized
production.
More
excitingly,
camelid‐specific
amino
acid
sequences
in
framework
mutated
their
human
equivalent,
which
is
humanized,
a
wide
range
applications.
These
superior
characteristics
make
nanobody
an
ideal
alternative
antibody,
showing
prospects
for
various
applications
structural
biology,
molecular
imaging,
disease
diagnosis
therapy,
agricultural
products,
environmental
chemicals
detection.
With
continuous
updating
theories
rapid
development
technology,
screening
expression
methods
increasingly
mature.
Consequently,
several
technologies
identify
express
been
established,
use
cases
described.
In
this
review,
we
summarize
recent
advances
discovery
production
novel
nanobodies,
detection
platforms.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(19), P. 19359 - 19371
Published: Oct. 2, 2023
The
multimodal
lateral
flow
immunoassay
(LFIA)
has
provided
accurate
and
reliable
results
for
fast
immediate
detection.
Nonetheless,
LFIA
remains
challenging
to
develop
biosensors
with
high
sensitivity
tolerance
matrix
interference
in
agro-food.
In
this
study,
we
developed
a
self-assembled
multivalent
fluorescence-nanobody
(Nb26-EGFP-H6)
16.5-fold
30-fold
higher
affinity
than
monovalent
nanobody
(Nb26).
Based
on
the
Nb26-EGFP-H6,
synthesized
enhanced
immune-probes
Zn-CN@Nb26-EGFP-H6
by
pyrolyzing
oxidizing
an
imidazolating
zeolite
framework-8
(ZIF-8)
obtain
photothermal
metal–carbon
nanomaterials
(Zn-CN)
immobilizing
Nb26-EGFP-H6.
rough
porous
structure
of
Zn-CN
large
surface
area
facilitates
enrichment
immobilization
antibodies.
A
trimodal
(tLFIA)
colorimetric,
fluorescent,
triple
signal
outputs
was
constructed
detection
aflatoxin
B1
(AFB1)
maize.
Attractively,
Zn-CN-based
tLFIA's
multiplex
guarantees
sensitive
AFB1,
limits
0.0012
ng/mL
(colorimetric
signals),
0.0094
(fluorescent
0.252
(photothermal
signals).
trimode
immunosensor
628-fold
42-fold
that
original
Nb26-based
ELISA
(IC50)
unimodal
(LOD).
This
work
provides
idea
constructing
sensitive,
tolerant
efficient
analytical
platform
rapidly
detecting
AFB1
food.
Despite
the
constant
advances
in
fluorescence
imaging
techniques,
monitoring
endogenous
proteins
still
constitutes
a
major
challenge
particular
when
considering
dynamics
studies
or
super-resolution
imaging.
We
have
recently
evolved
specific
protein-based
binders
for
PSD-95,
main
postsynaptic
scaffold
at
excitatory
synapses.
Since
synthetic
recombinant
recognize
epitopes
not
directly
involved
target
protein
activity,
we
consider
them
here
as
tools
to
develop
PSD-95
probes.
After
confirming
their
lack
of
impact
on
function,
validated
use
intrabody
fluorescent
further
engineered
probes
and
demonstrated
usefulness
different
modalities
(STED,
PALM,
DNA-PAINT)
both
live
fixed
neurons.
Finally,
exploited
enrich
synapse
genetically
encoded
calcium
reporters.
Overall,
demonstrate
that
these
constitute
robust
efficient
platform
selectively
monitor
using
various
techniques.
Chemical Society Reviews,
Journal Year:
2020,
Volume and Issue:
50(2), P. 1219 - 1250
Published: Dec. 8, 2020
Parkinson's
disease
(PD),
as
the
second
most
common
neurodegenerative
disease,
is
caused
by
complex
pathological
processes
and
currently
remains
very
difficult
to
treat.
PD
brings
great
distress
patients
imposes
a
heavy
economic
burden
on
society.
The
number
of
growing
aging
population
increases
worldwide.
Therefore,
it
crucial
develop
new
tools
for
aiding
early
diagnosis
treatment
PD.
significant
features
involved
in
include
abnormal
accumulation
α-synuclein,
metal
ion
dyshomeostasis,
oxidative
stress,
mitochondrial
dysfunction
neurotransmitter
deficiencies.
In
recent
years,
fluorescent
probes
have
emerged
powerful
bioimaging
tool
with
potential
help
understand
via
detection
monitoring
features.
this
review,
we
comprehensively
summarize
design
working
mechanisms
along
their
applications
various
biomarkers.
We
also
discuss
current
limitations
provide
perspectives
how
these
can
be
overcome
better
suitable
application
clinical
trials
future.
hope
that
review
provides
valuable
information
guidance
development
used
clinically
contributes
efficient
drugs
Journal of Nanobiotechnology,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: March 31, 2022
Salmonella
Enteritidis
(S.
Enteritidis)
being
one
of
the
most
prevalent
foodborne
pathogens
worldwide
poses
a
serious
threat
to
public
safety.
Prevention
zoonotic
infectious
disease
and
controlling
risk
transmission
S.
Enteriditidis
critically
requires
evolution
rapid
sensitive
detection
methods.
The
methods
based
on
nucleic
acid
conventional
antibodies
are
fraught
with
limitations.
Many
these
limitations
can
be
circumvented
using
natural
nanobodies
which
endowed
characteristics,
such
as
high
affinity,
thermal
stability,
easy
production,
especially
higher
diversity.
This
study
aimed
select
special
against
for
developing
an
improved
nanobody-horseradish
peroxidase-based
sandwich
ELISA
detect
in
practical
sample.
peroxidase
fusions
help
eliminating
use
secondary
labeled
horseradish
peroxidase,
reduce
time
experiment.
Moreover,
novel
developed
this
used
specifically
rapidly
sensitivity.This
screened
four
from
immunized
nanobody
library,
after
rounds
screening,
phage
display
technology.
Subsequently,
were
successfully
expressed
prokaryotic
eukaryotic
expression
systems,
respectively.
A
employing
SE-Nb9
peroxidase-Nb1
pair
capture
Enteritidis,
respectively,
was
found
possess
limit
5
×
104
colony
forming
units
(CFU)/mL.
In
established
immunoassay,
8
h-enrichment
enabled
up
approximately
10
CFU/mL
milk
samples.
Furthermore,
we
investigated
colonization
distribution
infected
chicken
assay,
showing
that
could
subsist
almost
all
parts
intestinal
tract.
These
results
agreement
obtained
real-time
PCR
plate
culture.
liver
identified
colonized
quite
several
Enteriditidis,
indicating
infection
outside
tract.This
newly
antibody
spike
sample
analyze
chicken.
demonstrated
assay
is
applicable
detecting
spiked
rapid,
specific,
way.
Meanwhile,
challenged
indicate
it
promising
tool
monitoring
poultry
products.
Importantly,
SE-Nb1-vHRP
directly
bind
captured
by
SE-Nb9,
reducing
commercial
shortening
time.
short,
ushers
great
prospects
food
safety
control
further
production.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
12
Published: Jan. 18, 2022
Recombinant
antibodies
such
as
nanobodies
are
progressively
demonstrating
to
be
a
valid
alternative
conventional
monoclonal
also
for
clinical
applications.
Furthermore,
they
do
not
solely
represent
substitute
but
their
unique
features
allow
expanding
the
applications
of
biotherapeutics
and
changes
pattern
disease
treatment.
Nanobodies
possess
double
advantage
being
small
simple
engineer.
This
combination
has
promoted
extremely
diversified
approaches
design
nanobody-based
constructs
suitable
particular
Both
format
geometry
possibilities
functionalization
strategies
have
been
widely
explored
provide
macromolecules
with
better
efficacy
respect
single
or
combination.
Nanobody
multimers
nanobody-derived
reagents
were
developed
image
contrast
several
cancer
diseases
shown
effectiveness
in
animal
models.
Their
capacity
block
more
independent
signaling
pathways
simultaneously
is
considered
critical
avoid
tumor
resistance,
whereas
mass
these
multimeric
compounds
still
remains
significantly
smaller
than
that
an
IgG,
enabling
deeper
penetration
solid
tumors.
When
applied
CAR-T
cell
therapy,
can
effectively
improve
specificity
by
targeting
multiple
epitopes
consequently
reduce
side
effects.
represents
great
potential
treating
malignant
lymphomas,
acute
myeloid
leukemia,
lymphoblastic
myeloma
Apart
from
treatment,
multispecific
drugs
imaging
built
nanobody
blocks
demonstrated
value
detecting
tackling
neurodegenerative,
autoimmune,
metabolic,
infectious
antidotes
toxins.
In
particular,
multi-paratopic
recently
passive
immunization
against
SARS-CoV-2
goal
impairing
variant
survival
due
resistance
epitopes.
Given
enormous
research
activity
field,
it
expected
molecules
will
undergo
late
trials
next
future.
Systematic
Review
Registration.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Aug. 5, 2022
Abstract
Fluorescence
imaging
is
one
of
the
most
versatile
and
widely-used
tools
in
biology
1
.
Although
techniques
to
overcome
diffraction
barrier
were
introduced
more
than
two
decades
ago,
nominal
attainable
resolution
kept
improving
2,
3
,
fluorescence
microscopy
still
fails
image
morphology
single
proteins
or
small
molecular
complexes,
either
purified
a
cellular
context
4,
5
Here
we
report
solution
this
problem,
form
o
ne-step
n
anoscale
e
xpansion
(ONE)
microscopy.
We
combined
10-fold
axial
expansion
specimen
(1000-fold
by
volume)
with
fluctuation
analysis
6,
7
enable
description
cultured
cells,
tissues,
viral
particles,
complexes
proteins.
At
level,
using
immunostaining,
our
technology
revealed
detailed
nanoscale
arrangements
synaptic
proteins,
including
quasi-regular
organisation
PSD95
clusters.
molecule
upon
main
chain
fluorescent
labelling,
could
visualise
shape
individual
membrane
soluble
Moreover,
conformational
changes
undergone
∼17
kDa
protein
calmodulin
Ca
2+
binding
readily
observable.
also
imaged
classified
aggregates
cerebrospinal
fluid
samples
from
Parkinson’s
Disease
(PD)
patients,
which
represents
promising
new
development
towards
improved
PD
diagnosis.
ONE
compatible
conventional
microscopes
can
be
performed
software
provide
here
as
free,
open-source
package.
This
bridges
gap
between
high-resolution
structural
light
microscopy,
provides
avenue
for
discoveries
medicine.
Nature Biotechnology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 9, 2024
The
attainable
resolution
of
fluorescence
microscopy
has
reached
the
subnanometer
range,
but
this
technique
still
fails
to
image
morphology
single
proteins
or
small
molecular
complexes.
Here,
we
expand
specimens
at
least
tenfold,
label
them
with
conventional
fluorophores
and
light
microscopes,
acquiring
videos
in
which
analyze
fluctuations.
One-step
nanoscale
expansion
(ONE)
enables
visualization
shapes
individual
membrane
soluble
proteins,
achieving
around
1-nm
resolution.
We
show
that
conformational
changes
are
readily
observable,
such
as
those
undergone
by
~17-kDa
protein
calmodulin
upon
Ca2+
binding.
ONE
is
also
applied
clinical
samples,
analyzing
aggregates
cerebrospinal
fluid
from
persons
Parkinson
disease,
potentially
aiding
disease
diagnosis.
This
technology
bridges
gap
between
high-resolution
structural
biology
techniques
microscopy,
providing
new
avenues
for
discoveries
medicine.
Combining
super-resolution
radial
fluctuations
captures
proteins.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(9), P. 2158 - 2158
Published: Sept. 23, 2024
Cancer
immunotherapy
has
emerged
as
a
transformative
approach
in
oncology,
utilizing
the
body’s
immune
system
to
specifically
target
and
destroy
malignant
cells.
This
review
explores
scope
impact
of
various
immunotherapeutic
strategies,
including
monoclonal
antibodies,
chimeric
antigen
receptor
(CAR)-T
cell
therapy,
checkpoint
inhibitors,
cytokine
therapeutic
vaccines.
Monoclonal
such
Rituximab
Trastuzumab,
have
revolutionized
treatment
paradigms
for
lymphoma
breast
cancer
by
offering
targeted
interventions
that
reduce
off-target
effects.
CAR-T
therapy
presents
potentially
curative
option
refractory
hematologic
malignancies,
although
challenges
remain
effectively
treating
solid
tumors.
Checkpoint
inhibitors
redefined
management
cancers
like
melanoma
lung
cancer;
however,
managing
immune-related
adverse
events
ensuring
durable
responses
are
critical
areas
focus.
Cytokine
continues
play
vital
role
modulating
response,
with
advancements
engineering
improving
specificity
reducing
systemic
toxicity.
Therapeutic
vaccines,
particularly
mRNA-based
represent
frontier
personalized
treatment,
aiming
generate
robust,
long-lasting
against
tumor-specific
antigens.
Despite
these
advancements,
field
faces
significant
challenges,
resistance,
tumor
heterogeneity,
immunosuppressive
microenvironment.
Future
research
should
address
obstacles
through
emerging
technologies,
next-generation
Clustered
Regularly
Interspaced
Short
Palindromic
Repeat
(CRISPR)-based
gene
editing,
AI-driven
drug
discovery.
By
integrating
novel
approaches,
holds
promise
more
durable,
less
toxic,
highly
options,
ultimately
patient
outcomes
survival
rates.